3 Growth Companies With Insider Ownership Up To 38%
Amneal Pharmaceuticals, Inc. Class A AMRX | 0.00 |
The United States market has shown positive momentum, with a 1.2% increase over the last week and an impressive 18% rise over the past year, while earnings are projected to grow by 17% annually. In this favorable environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment of interests between shareholders and management.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Uxin (UXIN) | 34.3% | 69.4% |
| Upstart Holdings (UPST) | 13.9% | 65.6% |
| Precigen (PGEN) | 11.7% | 55.4% |
| Nu Holdings (NU) | 22.8% | 20% |
| Karman Holdings (KRMN) | 14.5% | 54% |
| Himax Technologies (HIMX) | 29.2% | 70.2% |
| Dave (DAVE) | 17% | 23.2% |
| Carlyle Group (CG) | 27.5% | 20.5% |
| Astera Labs (ALAB) | 10% | 33.2% |
| Almonty Industries (ALM) | 10.8% | 38% |
We're going to check out a few of the best picks from our screener tool.
Quantum Computing (QUBT)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Quantum Computing Inc. is an integrated photonics company that supplies quantum machines to both commercial and government sectors in the United States, with a market cap of $1.89 billion.
Operations: The company's revenue is primarily derived from its Software & Programming segment, which generated $9.82 million.
Insider Ownership: 11.2%
Quantum Computing Inc. is poised for rapid growth, with revenue expected to increase by 59.2% annually, outpacing the US market average. Despite recent shareholder dilution and a volatile share price, the company is on track to achieve profitability within three years. Recent strategic moves include seeking acquisitions and partnerships to enhance their photonics and semiconductor capabilities, supported by a robust balance sheet. The addition of Susan G. Hunt as Chief Revenue Officer aims to bolster their commercial strategy amid expanding AI applications.
Amneal Pharmaceuticals (AMRX)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company involved in the development, manufacturing, marketing, and distribution of generics, injectables, biosimilars, and specialty branded pharmaceutical products across various regions including the United States, India, and Ireland with a market cap of $6.27 billion.
Operations: Amneal Pharmaceuticals generates revenue through its segments, with Avkare contributing $732.28 million, Specialty accounting for $574.73 million, and Affordable Medicines bringing in $1.81 billion.
Insider Ownership: 38.2%
Amneal Pharmaceuticals exhibits potential for growth, with earnings projected to rise significantly over the next three years. Despite trading below estimated fair value, insider selling has been notable recently. The company raised its 2026 earnings guidance and reported strong Q2 results, with net income more than doubling year-over-year. Recent FDA approvals for iohexol and romidepsin injections enhance its product portfolio, while strategic partnerships aim to expand generic offerings in diabetes treatment markets.
Tutor Perini (TPC)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Tutor Perini Corporation is a construction company offering general contracting, construction management, and design-build services to private and public clients both in the United States and internationally, with a market cap of $4.65 billion.
Operations: The company's revenue is derived from three main segments: Civil (Including Management Services) at $3.26 billion, Building (Including Management Services) at $2.09 billion, and Specialty Contractors at $969.81 million.
Insider Ownership: 14.2%
Tutor Perini shows potential for growth, with earnings projected to rise significantly over the next three years, outpacing the US market. Despite trading below estimated fair value and recent insider selling, its Q2 results were strong with net income improving substantially year-over-year. The company maintains double-digit revenue growth guidance for 2026 and has secured significant contracts, including a US$69.5 million project in Death Valley and a US$651.8 million task order from NAVFAC Pacific.
Make It Happen
- Delve into our full catalog of 186 Fast Growing US Companies With High Insider Ownership here.
- Want To Explore Some Alternatives? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
